Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Not Yet Recruiting

Sacituzumab Tirumotecan vs MMAE-ADCs in Advanced Urothelial Carcinoma (FUSCC-SPARE-UC-01)

NCT07662863

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +19 more
Locations: Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

NCT06770855

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Not Yet Recruiting

STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy

NCT07655284

Conditions: Bladder Cancer Requiring Cystectomy, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +10 more
Locations: Brigham and Women's Hospital Boston, Massachusetts, United States

Instituto do Câncer do Estado de São Paulo (ICESP) São Paulo, Brazil

View Trial Details

Not Yet Recruiting

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

NCT07636785

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +49 more
Locations: HonorHealth Research Institute Scottsdale, Arizona, United States

View Trial Details

Not Yet Recruiting

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

NCT07645742

Conditions: Adenocarcinoma, Cancer (Advanced Stage), Carcinoma, +29 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Neoadjuvant Enfortumab Vedotin Plus Pembrolizumab in Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Carcinoma

NCT07643519

Conditions: Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Prehabilitation in High-risk Oncologic Surgery

NCT07638410

Conditions: Abdominal Surgery Complications, Adnexal Diseases, Bladder Cancer, +43 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Multi-Omics-Based Phase Ⅱ Trial of Trastuzumab Rezetecan Plus Camrelizumab for Perioperative Therapy in HER2-Positive Muscle-Invasive Urothelial Carcinoma

NCT07639983

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Registry of Minimally Invasive Cancer Treatment Using Spectral Angio-CT Image Guidance

NCT07636148

Conditions: Adenocarcinoma, Bone Cancer Metastatic, Bone Cancer Tumor, +46 more
Locations: Hospices Civils de Lyon - Hôpital Édouard Herriot Lyon, Auvergne-Rhône-Alpes, France

Assistance Publique Hopitaux de Paris - Hôpital Henri Mondor Créteil, Île-de-France Region, France

Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Not Yet Recruiting

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

NCT07332351

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions